Thermo Fisher Scientific announced it will acquire Mesa Biotech for approximately $450 million in cash, with up to an additional $100 million in cash upon the completion of certain milestones.
The Hanmi Covid-19 Quick Test, an antigen test that can detect COVID-19 infection within 30 minutes, will be released by Hanmi Pharmaceutical by February.
Researchers from the Washington University School of Medicine in St. Louis have developed a blood test that can identify which patients with COVID-19 are at risk of severe disease or death and measures mitochondrial DNA present in the blood.
The FDA has given emergency use authorization to Ortho Clinical Diagnostics for its VITROS SARS-CoV-2 Antigen Test, a high-volume COVID-19 antigen test, and to MatMaCorp for its Covid-19 2SF RNA test.
A Series A financing round has raised $100 million for Delfi Diagnostics. The funds will be used to expand its team of machine learning experts and cancer researchers as well as to validate its next-generation blood-based cancer test.
The Biomedical Advanced Research and Development Authority has given DiaSorin Molecular additional funding to validate its Simplexa COVID-19 & Flu A/B Direct kit and its Simplexa COVID-19 Direct kit. The funds will also be used for studied needed to obtain 510(k) clearance from the FDA.
